Galectin Therapeutics
GALT
GALT
75 hedge funds and large institutions have $22.7M invested in Galectin Therapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
Holders
75
Holding in Top 10
–
Calls
$226K
Puts
$266K
Top Buyers
| 1 | +$632K | |
| 2 | +$273K | |
| 3 | +$115K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$112K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$79.7K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$402K | |
| 3 | -$237K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$169K |
| 5 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$162K |